Release of our first CSR Report!
We’re excited to announce the publication of our first CSR Report!
Press releases
May 10, 2021
Terasaki Institute Memorandum of Uderstanding
“The Terasaki Institute leads the world in the development of bioprintable, biopolymer-based technologies poised to revolutionize drug delivery, wearable and implantable devices. Jointly with HTL we expect to bring to life a new generation of biopolymer-based applications in critical sectors of precision and regenerative medicine,” added Maurizio Vecchione, Chief Innovation Officer of the Terasaki Institute for Biomedical Innovation.
Read more below.
To see our most recent news,
follow us on LinkedIn
Read more
news from us
-
Press releases June 5, 2025HTL Biotechnology inaugurates a new production line dedicated to sterile hyaluronic acid
As part of National Biomanufacturing Day 2025, HTL Biotechnology inaugurates a new production line dedicated to Hyaluronic Acid.
-
Press releases May 27, 2025HTL Biotechnology supports National Biomedicines manufacturing Day
HTL Biotechnology is proud to support National Biomedicines manufacturing Day, which will take place on June 5, 2025.
-
Articles April 2, 2025François Fournier Featured in Korean Press
HTL Biotechnology CEO François Fournier spoke to leading Korean media DongA Ilbo, reaffirming Korea’s strategic importance and the strong, long-standing ties with Korean customers.